4.4 Article

Circulating Levels of Endothelial Progenitor Cell Mobilizing Factors in the Metabolic Syndrome

Journal

AMERICAN JOURNAL OF CARDIOLOGY
Volume 106, Issue 11, Pages 1606-1608

Publisher

EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjcard.2010.07.039

Keywords

-

Funding

  1. National Institutes of Health, Bethesda, Maryland [K-24 AT00596]
  2. American Diabetes Association, Alexandria, Virginia

Ask authors/readers for more resources

Endothelial progenitor cells (EPCs) are an emerging biomarker of vascular health. However, there are few data on the biology and mobilizing factors of EPCs in metabolic syndrome (MS). The aim of this study was to assay EPC mobilizing factors, including granulocyte colony-stimulating factor, stem cell factor/c-kit ligand (SCF), vascular endothelial growth factor, and stromal cell derived factor-1 levels, in patients with MS (n = 36) and age- and gender-matched controls (n = 38). There was a significant reduction of 83% in granulocyte colony-stimulating factor levels in patients with MS. Also, there were decreases in SCF and SCF soluble receptor levels. However, there was no significant difference in stromal cell-derived factor-1 levels, and paradoxically, vascular endothelial growth factor levels were increased, consistent with resistance. In conclusion, in addition to progenitor cell exhaustion as a mechanism for the decrease in EPCs in patients with MS, they also have a mobilization defect, as manifested by decreased levels of granulocyte colony-stimulating factor and SCF, resulting in a decrease in EPCs. (C) 2010 Elsevier Inc. All rights reserved. (Am J Cardiol 2010;106:1606-1608)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Cardiac & Cardiovascular Systems

Clinical efficacy and safety of angiogenesis inhibitors: sex differences and current challenges

Andrea Cignarella, Gian Paolo Fadini, Chiara Bolego, Lucia Trevisi, Carlotta Boscaro, Viola Sanga, Teresa Maria Seccia, Antonio Rosato, Gian Paolo Rossi, Matthias Barton

Summary: This review discusses the challenges clinicians face in angiogenesis inhibitor therapy, including the need to consider sex differences in clinical efficacy and safety, and proposes future research directions.

CARDIOVASCULAR RESEARCH (2022)

Article Biochemistry & Molecular Biology

Hematopoietic and Nonhematopoietic p66Shc Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in Diabetes

Mattia Albiero, Marianna D'Anna, Benedetta Maria Bonora, Gaia Zuccolotto, Antonio Rosato, Marco Giorgio, Elisabetta Iori, Angelo Avogaro, Gian Paolo Fadini

Summary: For the first time, this study explores the hematopoietic and nonhematopoietic roles of p66Shc in regulating HSPC traffic and ischemic responses. Hematopoietic deletion of p66Shc is sufficient to rescue HSPC mobilization and homing in diabetes after ischemia and improves blood flow recovery. Inhibiting p66Shc in blood cells may be a novel strategy to counter PAD in diabetes.

ANTIOXIDANTS & REDOX SIGNALING (2022)

Review Endocrinology & Metabolism

Challenges and opportunities in real-world evidence on the renal effects of sodium-glucose cotransporter-2 inhibitors

Gian Paolo Fadini, Stefano Del Prato, Angelo Avogaro, Anna Solini

Summary: With the increasing global population aging and prevalence of type 2 diabetes, prevention of diabetic complications remains a major challenge. SGLT2 inhibitors have been proven to reduce DKD progression and improve cardiovascular outcomes, but critical challenges such as channelling bias and database heterogeneity need to be addressed in research studies.

DIABETES OBESITY & METABOLISM (2022)

Article Endocrinology & Metabolism

Glycemic control after switching to faster aspart in adults with type 1 diabetes

G. P. Fadini, F. Boscari, D. Falaguasta, S. Ferretto, A. Maran, A. Avogaro, D. Bruttomesso

Summary: In routine care, patients with type 1 diabetes who switched to faster insulin aspart (FIA) experienced a reduction in the time spent in hyperglycemia > 250 mg/dl during daytime and an increase in time in range. These improvements were particularly significant for patients with higher baseline HbA1c levels.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2022)

Editorial Material Endocrinology & Metabolism

Perturbation of Glucose Homeostasis During Acute Illness: Stress Hyperglycemia and Relative Hypoglycemia

Gian Paolo Fadini

DIABETES CARE (2022)

Article Endocrinology & Metabolism

Infection Rates and Impact of Glucose Lowering Medications on the Clinical Course of COVID-19 in People with Type 2 Diabetes: A Retrospective Observational Study

Francesca Mannucci, Giacomo Vitturi, Luca Benacchio, Luca Gino Sbrogio, Francesca Bano, Annunziata Lapolla, Francesco Piarulli, Maria Cecilia Giron, Angelo Avogaro, Gian Paolo Fadini

Summary: Diabetes does not appear to significantly modify the risk of SARS-CoV-2 infection, but it does increase the rates of hospitalization and death. Insulin use is associated with worse outcomes, while metformin use is associated with lower mortality.

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2022)

Article Cardiac & Cardiovascular Systems

Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care

Mario Luca Morieri, Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Angelo Avogaro, Gian Paolo Fadini

Summary: This observational study found that managing patients with T2D according to international standards for pharmacological management based on a treat-to-benefit approach was associated with a lower risk of major adverse cardiovascular events, heart failure, and mortality. These results provide ex-post validation of the ADA/EASD treatment algorithm.

CARDIOVASCULAR DIABETOLOGY (2022)

Article Endocrinology & Metabolism

Loss of Hematopoietic Cell-Derived Oncostatin M Worsens Diet-Induced Dysmetabolism in Mice

Mattia Albiero, Stefano Ciciliot, Anna Rodella, Ludovica Migliozzi, Francesco Ivan Amendolagine, Carlotta Boscaro, Gaia Zuccolotto, Antonio Rosato, Gian Paolo Fadini

Summary: Innate immune cells infiltrate and spread inflammatory signals in growing adipose tissue, leading to glucose intolerance and insulin resistance in distant tissues. Oncostatin M (OSM), a cytokine, is debated for its role in the metabolic consequences of overfeeding. Through this study, it was found that OSM is required during obesity development, as its concentrations are dynamically regulated during a high-fat diet. Osm(-/-) mice showed glucose intolerance, impaired muscle glucose uptake, and worsened liver inflammation and damage, demonstrating the importance of OSM in adapting to overfeeding.

DIABETES (2023)

Editorial Material Cardiac & Cardiovascular Systems

Deciphering dementia in the cardiometabolic continuum

Gian Paolo Fadini, Mario Luca Morieri

EUROPEAN HEART JOURNAL (2023)

Article Endocrinology & Metabolism

Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study

M. L. Morieri, I. Raz, A. Consoli, M. Rigato, A. Lapolla, F. Broglio, E. Bonora, A. Avogaro, G. P. Fadini

Summary: This study compared the effectiveness of dapagliflozin to DPP-4 inhibitors in achieving individualized HbA1c targets and extra-glycaemic endpoints in elderly patients with type 2 diabetes. The results showed that patients initiating dapagliflozin had a lower likelihood of reaching individualized HbA1c targets compared to those initiating DPP-4 inhibitors. However, they experienced greater improvements in body weight and blood pressure.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2023)

Article Endocrinology & Metabolism

Efficacy of Dapagliflozin in Southern Europe Across the Spectrum of Characteristics of Type 2 Diabetes: An International Real-World Analysis

Gian Paolo Fadini, Cristobal Morales, Irene Caballero, Beatriz Gonzalez, Nikolaos Tentolouris, Agostino Consoli

Summary: This study extends a previous analysis of real-world data in patients with type 2 diabetes initiating dapagliflozin in Italy, Greece, and Spain. The results confirm the efficacy of dapagliflozin in reducing HbA1c in diverse real-world settings, with similar effects across countries and baseline characteristics.

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2022)

Article Endocrinology & Metabolism

Putative circulating adipose tissue-derived stem cells, obesity, and metabolic syndrome features

B. M. Bonora, R. Cappellari, M. Albiero, L. Prevedello, M. Foletto, R. Vettor, A. Avogaro, G. P. Fadini

Summary: This study examined adipose tissue-derived stem cells (ASCs) in individuals with metabolic syndrome traits and found that these cells can enter the systemic circulation and establish ectopic adipose depots, leading to insulin resistance. This phenomenon, previously observed in mice, has been confirmed in humans, highlighting the importance of further investigation.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2023)

Article Endocrinology & Metabolism

Safety of sodium-glucose cotransporter 2 inhibitors in elderly patients with type 2 diabetes: A meta-analysis of randomized controlled trials

Mauro Rigato, Gian Paolo Fadini, Angelo Avogaro

Summary: This study aimed to assess the safety of SGLT2 inhibitors (SGLT2is) in elderly patients with type 2 diabetes. A meta-analysis of randomized controlled trials (RCTs) showed that SGLT2is were well tolerated in the elderly, but older patients were underrepresented in clinical trials.

DIABETES OBESITY & METABOLISM (2023)

Review Endocrinology & Metabolism

Recent developments in targets for ischemic foot disease

Jonathan Golledge, Shivshankar Thanigaimani, Kristen S. Barratt, Gian Paolo Fadini

Summary: Diabetes is a major risk factor for ischaemic foot disease, which can lead to severe complications such as tissue loss and amputation. Current treatment options focus on revascularisation, but there are limitations in both surgical eligibility and success rates. Recent research in animal models and clinical trials have identified potential novel medical targets for ischaemia, aiming to improve wound healing and enhance blood supply recovery. However, translating these findings to human patients remains challenging due to limitations in clinically relevant animal models. Promising results have been reported in small clinical trials with certain therapies, but further research and larger clinical trials are needed to determine their broader applicability.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)

Article Endocrinology & Metabolism

Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells

Benedetta Maria Bonora, Mario Luca Morieri, Marella Marassi, Roberta Cappellari, Angelo Avogaro, Gian Paolo Fadini

Summary: This study aimed to investigate whether measuring circulating levels of haematopoietic stem/progenitor cells (HSPCs) can improve the prediction of long-term kidney outcomes in individuals with type 2 diabetes. The results showed that HSPC levels are associated with worsening kidney function and can enhance the identification of adverse kidney outcomes in individuals with type 2 diabetes.

DIABETOLOGIA (2023)

Editorial Material Cardiac & Cardiovascular Systems

Toward Optimizing Antiplatelet Therapy for Patients at High Bleeding Risk

Jose E. Exaire, Timothy A. Mixon

AMERICAN JOURNAL OF CARDIOLOGY (2024)

Article Cardiac & Cardiovascular Systems

Influence of the Type of Disability and Sporting Discipline on Lipid Profile in a Cohort of Italian Paralympic Athletes

Giuseppe Di Gioia, Federica Coletti, Lorenzo Buzzelli, Viviana Maestrini, Sara Monosilio, Andrea Segreti, Maria Rosaria Squeo, Erika Lemme, Antonio Nenna, Antonio Pelliccia

Summary: Dyslipidemia is common in Paralympic athletes, with lipid levels influenced by the type of disability and sporting discipline.

AMERICAN JOURNAL OF CARDIOLOGY (2024)

Article Cardiac & Cardiovascular Systems

Can GRACE Risk Score Predict Mortality and the Need for Thrombolytic Treatment in Acute Pulmonary Embolism?

Esra Donmez, Sevgi Ozcan, Irfan Sahin, Murat Ziyrek, Ertugrul Okuyan

Summary: This study aimed to evaluate the predictive value of the GRACE risk score in acute pulmonary embolism (PE) patients for 30-day mortality and the need for thrombolytic treatment. The study found that the GRACE risk score, along with the PESI score, were independent risk factors associated with 30-day mortality and the need for thrombolytic treatment. The GRACE risk score showed high sensitivity and specificity in predicting mortality, and its combination with the PESI score helped define high-risk PE patients and predict poor prognosis.

AMERICAN JOURNAL OF CARDIOLOGY (2024)

Article Cardiac & Cardiovascular Systems

Echocardiography Versus Magnetic Resonance Imaging Quantification and Novel Algorithm for Isolated Severe Tricuspid Regurgitation

Tom Kai Ming Wang, Reza Reyaldeen, Kevser Akyuz, Zoran B. Popovic, A. Marc Gillinov, Bo Xu, Brian P. Griffin, Milind Y. Desai

Summary: Transthoracic echocardiography (TTE) is commonly used to evaluate isolated tricuspid regurgitation (TR), but there is limited research comparing its quantification with magnetic resonance imaging (MRI). In this study, a novel TTE algorithm was developed to identify severe TR based on TTE parameters. The algorithm had a higher accuracy than the current guidelines' criteria in detecting severe TR by MRI.

AMERICAN JOURNAL OF CARDIOLOGY (2024)

Editorial Material Cardiac & Cardiovascular Systems

Social Vulnerability and Hemopericardial Cardiovascular Death: Insight from the Centers for Disease Control and Prevention Databases

Enkhtsogt Sainbayar, Ramzi Ibrahim, Hoang Nhat Pham, Wisam Beauti, Mahek Shahid, Natalie Hickerson, Mohammed Salih, Joao Paulo Ferreira, Mamas A. Mamas

AMERICAN JOURNAL OF CARDIOLOGY (2024)

Article Cardiac & Cardiovascular Systems

Coronary Angiography and Chronic Total Occlusion Angioplasty in a Patient With Situs Inversus from the Right Radial Approach

Richard E. Casazza, Hymie Chera, Carlos Adolfo Rodriguez, Sergey Ayzenberg

Summary: This article presents a case of a patient with known situs inversus who underwent cardiac catheterization and was found to have chronic total occlusion in the right coronary artery. Situs inversus is a rare congenital abnormality characterized by the inverted position of chest and abdominal organs. Cardiac catheterization is uncommon in patients with this particular abnormality, highlighting the importance of customizing techniques to engage coronary arteries and optimize guide support for percutaneous coronary intervention if needed.

AMERICAN JOURNAL OF CARDIOLOGY (2024)

Editorial Material Cardiac & Cardiovascular Systems

Major Adverse Cardiac Events After Fractional Flow Reserve, Instantaneous Wave-Free Ratio, or Angiography-Guided Revascularization in Atrial Fibrillation: A Retrospective Study

Georgiana Pintea Bentea, Brahim Berdaoui, Sophie Samyn, Marielle Morissens, Philippe van de Borne, Jose Castro Rodriguez

AMERICAN JOURNAL OF CARDIOLOGY (2024)

Article Cardiac & Cardiovascular Systems

Pericardial Adipose Tissue Thrombospondin-1 Associates With Antiangiogenesis in Ischemic Heart Disease

Bulbul Ahmed, Melissa G. Farb, Shakun Karki, Sophia D'Alessandro, Niloo M. Edwards, Noyan Gokce

Summary: This study evaluated the angiogenic capacity of adipose tissue in patients undergoing cardiac surgeries and found that patients with coronary artery disease (CAD) had reduced angiogenic capacity in their pericardial adipose tissue. Gene expression analysis revealed upregulated expression of the anti-angiogenic gene TSP-1 in CAD patients, with no significant differences in other angiogenic factors. Additionally, inhibiting TSP-1 expression significantly improved angiogenic deficiency in CAD patients.

AMERICAN JOURNAL OF CARDIOLOGY (2024)

Article Cardiac & Cardiovascular Systems

Evaluation of MADIT-II Risk Stratification Score Among Nationwide Registry of Heart Failure Patients With Primary Prevention Implantable Cardiac Defibrillators or Resynchronization Therapy Devices

Moshe Rav-Acha, Orli Wube, Oholi Tovia Brodie, Yoav Michowitz, Michael Ilan, Tal Ovdat, Robert Klempfner, Mahmud Suleiman, Ilan Goldenberg, Michael Glikson

Summary: The current guidelines recommend prophylactic implantable cardioverter-defibrillator (ICD) for patients with symptomatic heart failure (HF) and low left ventricular ejection fraction. However, not all patients will benefit from ICD treatment. This study evaluated the feasibility of using the MADIT-II-based Risk Stratification Score (MRSS) to predict the survival benefit of prophylactic ICDs in patients with HF. The results showed that different risk subgroups had varying levels of ICD survival benefit.

AMERICAN JOURNAL OF CARDIOLOGY (2024)

Article Cardiac & Cardiovascular Systems

Electromechanical Window and Spontaneous Ventricular Tachyarrhythmias in Takotsubo Syndrome

Ariel Banai, Rachel Retsky, Lior Lupu, Erez Levi, David Zahler, Omri Feder, Roei Merin, Yan Topilsky, Raphael Rosso, Shmuel Banai, Sami Viskin, Ehud Chorin

Summary: This study aims to evaluate the association between electromechanical window (EMW) and ventricular tachyarrhythmias in patients with Takotsubo syndrome (TTS). The study found that TTS patients had a lower EMW value, which was associated with an increased risk of ventricular tachyarrhythmias.

AMERICAN JOURNAL OF CARDIOLOGY (2024)

Article Cardiac & Cardiovascular Systems

Socioclinical Phenotyping in Patients With Atherosclerotic Cardiovascular Disease: A Latent Class Analysis

Harun Kundi, Kobina Hagan, Tamer Yahya, Garima Sharma, Sadeer Al-Kindi, Zulqarnain Javed, Khurram Nasir

Summary: Using latent class analysis (LCA), the study identified clinical, demographic, and social subphenotypes in ASCVD population and assessed the risk of all-cause and cardiovascular mortality across different socioclinical classes. The results showed that the younger, female, non-Hispanic Black or Hispanic individuals with a high burden of co-morbidities and unfavorable social determinants of health had the highest risk of mortality in the identified latent classes.

AMERICAN JOURNAL OF CARDIOLOGY (2024)

Article Cardiac & Cardiovascular Systems

Pericardiocentesis Outcomes in Patients With Pulmonary Hypertension: A Nationwide Analysis from the United States

Moises A. Vasquez, Mina Iskander, Mohammed Mustafa, Juan A. Quintero-Martinez, Antonio Luna, Joel Mintz, Jose Noy, Juan Uribe, Ivan Mijares, Eduardo de Marchena, Yiannis S. Chatzizisis

Summary: The benefits of pericardiocentesis (PC) in patients with pulmonary hypertension (PH) and pericardial effusions are unclear. The study found that PC in PH patients is associated with higher in-hospital mortality and rates of cardiovascular complications.

AMERICAN JOURNAL OF CARDIOLOGY (2024)

Article Cardiac & Cardiovascular Systems

Echocardiographic Characteristics of Left and Right Ventricular Longitudinal Function in Patients With a History of Cardiac Surgery

Ken Kuwajima, Mana Ogawa, Irving Ruiz, Hiroko Hasegawa, Nobuichiro Yagi, Florian Rader, Robert J. Siegel, Takahiro Shiota

Summary: After cardiac surgery, the longitudinal function of the right ventricle and left ventricle is reduced, despite preserved global functions. In particular, tricuspid annular plane systolic excursion (TAPSE) remains decreased after surgery.

AMERICAN JOURNAL OF CARDIOLOGY (2024)

Article Cardiac & Cardiovascular Systems

Understanding the Burden of 30-Day Readmission in Patients With Both Primary and Secondary Diagnoses of Heart Failure: Causes, Timing, and Impact of Co-Morbidities

Min -Jung Kim, Robert H. Aseltine Jr, Sara R. Tabtabai

Summary: This study evaluated the rates and causes of 30-day readmissions after discharge for heart failure (HF) as a primary and secondary diagnosis. The findings indicate that efforts to reduce readmission rates should include patients with secondary HF diagnosis, and surveillance should extend to 2 weeks postdischarge to identify at-risk patients.

AMERICAN JOURNAL OF CARDIOLOGY (2024)

Article Cardiac & Cardiovascular Systems

Reversed Septal Curvature Is Associated With Nonsustained Ventricular Tachycardia in Hypertrophic

Ya He, Jianzhong Zhou

Summary: This study aimed to examine the relation between reverse septal curvature (RSC) and nonsustained ventricular tachycardia (NSVT) in patients with hypertrophic cardiomyopathy (HCM). The study found that patients with RSC were younger and had a higher incidence of NSVT, and RSC was identified as a strong independent risk factor for NSVT.

AMERICAN JOURNAL OF CARDIOLOGY (2024)